SCHEDULE 13G/A: Millennium Management Discloses 3.1% Passive Stake in AngioDynamics, Inc.

Millennium Management LLC and its affiliates have reported a 3.1% passive ownership stake in AngioDynamics, Inc., holding 1,239,572 shares of common stock.

Summary

• Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have filed an Amendment No. 1 to Schedule 13G, disclosing their beneficial ownership in AngioDynamics, Inc.
• As of March 31, 2025, the reporting persons collectively beneficially own 1,239,572 shares of AngioDynamics, Inc. common stock.
• This ownership represents 3.1% of the outstanding common stock of AngioDynamics, Inc.
• The filing indicates that the shares are held with shared voting power and shared dispositive power among the reporting persons.
• The reporting persons certify that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of AngioDynamics, Inc.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing disclosing a passive ownership stake. While not inherently positive or negative, the presence of a notable institutional investor like Millennium Management can be viewed as a slight positive signal of interest in the company.

Positives

• The disclosure of a significant passive stake by a prominent institutional investor like Millennium Management LLC may signal institutional interest in AngioDynamics, Inc.

Risks

• No specific risks related to the issuer's operations or financial health are disclosed in this ownership filing.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance regarding AngioDynamics, Inc.'s future performance or operations.

Management Comments

• Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander certified that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of AngioDynamics, Inc., nor were they acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.

Industry Context

This filing is a routine disclosure of a passive investment stake by an institutional investor and does not provide specific analysis of broader industry trends or competitive landscape for AngioDynamics, Inc.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant institutional ownership, informing them of a new passive investor in the company.

Key Dates

Keywords

AngioDynamics, Millennium Management, SEC filing, Schedule 13G, passive investment, institutional ownership, common stock, beneficial ownership